InterCure Ltd. Form 6-K Summary
Reporting period: Form 6-K filed May 24, 2022, for the month of May 2022. The filing references interim results for the three months ended March 31, 2022, compared with the three months ended March 31, 2021.
Business Context and Filing Contents
InterCure Ltd. is an Israeli foreign private issuer filing annual reports on Form 20-F. The submission includes a May 16, 2022 press release, management’s discussion and analysis, and unaudited interim condensed consolidated financial statements.
Financial Highlights
The provided filing text contains only the Form 6-K cover page and exhibit descriptions. It does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.
Changes, Outlook, and Risks
The available text does not include the referenced press release, management discussion, financial statements, guidance, management commentary, risk disclosures, contingencies, or unusual items. Accordingly, no conclusions about changes versus the prior comparable period or future outlook can be drawn from the supplied content.
Investor Verification Items
- Obtain and review Exhibit 99.1, the May 16, 2022 press release.
- Verify revenue, profitability, cash flow, margins, cash balances, debt, and liquidity in Exhibits 99.2 and 99.3.
- Compare the three months ended March 31, 2022 with the corresponding 2021 period.
- Review management’s discussion for guidance, operating developments, risks, contingencies, and non-recurring items.
- Confirm that the interim financial statements are unaudited and assess any subsequent developments disclosed elsewhere in the filing package.